Evaluation the effect of azithromycin oral suspension on the mucositis in patients undergoing Hematopoietic Stem Cell Transplantatio
Not Applicable
- Conditions
- •C00-D49 Neoplasms.
- Registration Number
- IRCT201603093210N13
- Lead Sponsor
- Maria Tavakoli-Ardakani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All patients hospitalized in bone marrow transplantation and patients undergoing chemotherapy;Patients satisfaction to participate in the study
The exclusion criteria:
Unwillingness of patients to continue;Allergic reactions to medication or other subunits of mouthwash
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mucositis. Timepoint: first day of chemotherapy until engraftment day. Method of measurement: WHO scoring system.
- Secondary Outcome Measures
Name Time Method Fever grade. Timepoint: From the first day of chemotherapy until engraftment time. Method of measurement: Submit a fever above 38.5 ° C for patients.;The need fortotal parenteral nutrition(TPN). Timepoint: During the study period. Method of measurement: SignTthe daysof parenteral nutrition intake.